Scilex Insider Trades
NASDAQ: SCLXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 3 · $12.77M
- Shares bought / sold
- 0 / 20.66M
- Net activity
- Net selling $12.8 million
Scilex insider activity
Over the last 12 months, Scilex insiders reported 4 transactions on SEC Form 4: 0 open-market purchases and 3 sales. Insiders bought $0 and sold $12.8 million worth of stock, for net insider selling of $12.8 million. The largest seller was Scilex Holding Co, with $12.8 million in reported sales.
The most recent filing shows SCLX Stock Acquisition JV LLC (10% Owner) reporting a transaction in 500,000 shares on Jul 3, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SCLX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
SCLX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 3, 2026 | SCLX Stock Acquisition JV LLC10% Owner | other | 500,000 | — | Form 4 |
| Dec 30, 2025 | Scilex Holding Co10% Owner | Sale | 9,657,300 | $5.21M | Form 4 |
| Dec 29, 2025 | Scilex Holding Co10% Owner | Sale | 7,310,984 | $4.79M | Form 4 |
| Dec 26, 2025 | Scilex Holding Co10% Owner | Sale | 3,689,016 | $2.77M | Form 4 |
| Jan 21, 2025 | SCLX Stock Acquisition JV LLC10% Owner | other | 3,250,000 | — | Form 4 |
| Jan 16, 2025 | SCLX Stock Acquisition JV LLC10% Owner | other | 779,371 | — | Form 4 |
| Jan 2, 2025 | SCLX Stock Acquisition JV LLC10% Owner | other | 5,000,000 | — | Form 4 |
| Dec 18, 2024 | SHAH JAISIMSee Remarks | Buy | 30,000 | $13.80K | Form 4 |
| Oct 31, 2024 | Ji HenryExecutive Chairperson | Buy | 8,888 | $8.35K | Form 4 |
| Oct 29, 2024 | SHAH JAISIMSee Remarks | Buy | 32,000 | $31.67K | Form 4 |
| Oct 18, 2024 | Chun JayDirector | Buy | 5,000 | $4.75K | Form 4 |
| Oct 18, 2024 | Followwill DormanDirector | Buy | 1,000 | $990 | Form 4 |
| Oct 17, 2024 | Lemus DavidDirector | Buy | 2,000 | $1.80K | Form 4 |
| Oct 17, 2024 | Wu Yue AlexanderDirector | Buy | 20,000 | $18.99K | Form 4 |
| Oct 17, 2024 | Ji HenryExecutive Chairperson | Buy | 10,000 | $9.71K | Form 4 |
| Oct 16, 2024 | Ma Stephen HoiChief Financial Officer | Buy | 6,700 | $6.50K | Form 4 |
| Oct 16, 2024 | SHAH JAISIMSee Remarks | Buy | 30,000 | $29.75K | Form 4 |
| Jun 26, 2024 | Followwill DormanDirector | Option exercise | 1,000 | $1.37K | Form 4 |
| Jun 20, 2024 | Chun JayDirector | Option exercise | 5,000 | $7.05K | Form 4 |
| Jun 20, 2024 | Ma Stephen HoiChief Financial Officer | Option exercise | 2,000 | $2.82K | Form 4 |
| Jun 20, 2024 | SHAH JAISIMSee Remarks | Option exercise | 14,000 | $24.22K | Form 4 |
| Jun 20, 2024 | Wu Yue AlexanderDirector | Option exercise | 5,000 | $7.05K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4